BIOSPAIN 2026

This round table will explore the growing range of alternative funding instruments available to innovative biotech SMEs, from public equity markets to emerging deeptech investment funds backed by public-private initiatives.
Moderated by Óscar Salazar (Euro-Funding), the discussion will bring together representatives from BME Growth, ICO AXIS, and a listed Spanish biotech company to share practical insights on how different financing options can support sustainable growth at different stages of a company's journey. Panelists will discuss how BME Growth can serve as a strategic financing platform for innovative SMEs, address common misconceptions and concerns surrounding stock market listings, and share first-hand experiences of accessing public markets. The conversation will also examine the role of new deeptech funds in closing financing gaps and complementing traditional investment sources.
Attendees will gain a clearer understanding of how alternative financing mechanisms can expand the capital toolbox available to biotech companies, helping founders and executives make informed decisions as they scale their businesses and navigate an increasingly diverse funding landscape.